Similar articles

• Aripiprazole and neuroleptic malignant syndrome.

  Brunelle J, Guigueno S, Gouin P, Tamion F, Thibaut F. Brunelle J, et al. J Clin Psychopharmacol. 2007 Apr;27(2):212-4. doi: 10.1097/01.jcp.0000264967.62334.bc. J Clin Psychopharmacol. 2007. PMID: 17414250 No abstract available.
• [Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine].

  Lopez E, Fraile S, Hidalgo FJ, García B. Lopez E, et al. Med Clin (Barc). 2013 Sep 21;141(6):273-4. doi: 10.1016/j.medcli.2013.01.018. Epub 2013 Apr 8. Med Clin (Barc). 2013. PMID: 23578844 Spanish. No abstract available.
• Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic.

  [No authors listed] [No authors listed] Prescrire Int. 2009 Jun;18(101):117. Prescrire Int. 2009. PMID: 19637429 No abstract available.
• Aripiprazole for the maintenance treatment of bipolar I disorder: A review.

  McIntyre RS. McIntyre RS. Clin Ther. 2010;32 Suppl 1:S32-8. doi: 10.1016/j.clinthera.2010.01.022. Clin Ther. 2010. PMID: 20152551 Review.
• Aripiprazole for the treatment of bipolar disorder: a review of current evidence.

  Fagiolini A, Nitti M, Forgione RN, Marra FS, Casamassima F. Fagiolini A, et al. Expert Opin Pharmacother. 2011 Feb;12(3):473-88. doi: 10.1517/14656566.2011.552429. Expert Opin Pharmacother. 2011. PMID: 21254952 Review.